JILLIAN BRITO: Open Payments
NPI 1497294458 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 81 payments from 15 companies in 2025. Trend: 2023 $1,326 · 2024 $2,204 · 2025 $1,603
Food & beverage: $1,514Education: $89
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $300 |
| Ardelyx, Inc. | 13 | $277 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $218 |
| QOL Medical, LLC | 11 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $149 |
| Phathom Pharmaceuticals, Inc. | 7 | $92 |
| Janssen Biotech, Inc. | 1 | $89 |
| Novo Nordisk Inc | 2 | $55 |
| Intercept Pharmaceuticals, Inc. | 2 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
Products named: REZDIFFRA, IBSRELA, XIFAXAN, Sucraid, VOQUEZNA, TREMFYA, EOHILIA, ENTYVIO.
Industry payments across FL — which companies pay providers there.
